AECLY yields 3.44% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, AECLY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AECLY + PFE for your $10,000?
AECI Ltd, together with its subsidiaries, engages in the mining, water treatment, plant and animal health, food and beverage, infrastructure, and general industrial sectors in Africa, Europe, Southeast Asia, North America, South America, and Australia. The company operates through five segments: AECI Mining, AECI Water, AECI Agri Health, AECI Chemicals, and AECI Property Services & Corporate. The AECI Mining segment provides mine-to-mineral solution for the mining sector, which includes commercial explosives, initiating systems, and blasting services, as well as surfactants for explosives manufacture. The AECI Water segment provides integrated water treatment and process chemicals, and equipment solutions for various applications comprising public and industrial water, desalination, and utilities. The AECI Agri Health segment manufactures and distributes crop protection products, plant nutrients, animal premixes, specialty animal health products, and fine chemicals. The AECI Chemicals segment supplies raw materials and related services to customers in the food and beverage, manufacturing, road infrastructure, and general industrial sectors. The AECI Property Services & Corporate segment offers property leasing and management services in the office, industrial, and retail sectors. The company was founded in 1894 and is based in Sandton, South Africa.
Full AECLY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.